logo
Product categories

EbookNice.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link.  https://ebooknice.com/page/post?id=faq


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookNice Team

(Ebook) Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine) by Shaker A. Mousa ISBN 9781588290830, 9781592596584, 1588290832, 1592596584

  • SKU: EBN-2022290
Zoomable Image
$ 32 $ 40 (-20%)

Status:

Available

4.6

20 reviews
Instant download (eBook) Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine) after payment.
Authors:Shaker A. Mousa
Pages:320 pages.
Year:2003
Editon:1
Publisher:Humana Press
Language:english
File Size:1.69 MB
Format:pdf
ISBNS:9781588290830, 9781592596584, 1588290832, 1592596584
Categories: Ebooks

Product desciption

(Ebook) Anticoagulants, Antiplatelets, and Thrombolytics (Methods in Molecular Medicine) by Shaker A. Mousa ISBN 9781588290830, 9781592596584, 1588290832, 1592596584

1This collection of review articles highlights the latest development of antithrombotics and provides proven experimental methods for the further development of new and improved anticoagulants. Among the cutting-edge developments reviewed are the novel usage of low molecular weight heparins, such antithrombin agents as the hirudin, and such antiplatelet drugs as the GPIIb/IIIa inhibitors and ADP receptor antagonists. Additional innovations discussed include aspirin and clopidogrel, the expanded use of polytherapeutic approaches, antiproteases (factors IIa, Xa, and VIIa), tissue factor targeting, platelet receptor targeting, and antithrombin III modulation.
*Free conversion of into popular formats such as PDF, DOCX, DOC, AZW, EPUB, and MOBI after payment.

Related Products